These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38307808

  • 1. A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma.
    Igari S, Yamamoto M, Kikuchi N, Ohtsuka M, Yamamoto T.
    An Bras Dermatol; 2024; 99(3):450-451. PubMed ID: 38307808
    [No Abstract] [Full Text] [Related]

  • 2. Refractory myasthenia gravis exacerbation triggered By pembrolizumab.
    Earl DE, Loochtan AI, Bedlack RS.
    Muscle Nerve; 2018 Apr; 57(4):E120-E121. PubMed ID: 29193151
    [No Abstract] [Full Text] [Related]

  • 3. Pembrolizumab-Induced Alopecia Areata.
    Elshimy N, Blakeway E, Mitra A.
    Skinmed; 2019 Apr; 17(2):142-143. PubMed ID: 31145074
    [No Abstract] [Full Text] [Related]

  • 4. Diffuse Hepatic Infiltration by Metastatic Melanoma.
    Velázquez HE, Castro-Alonso FJ, Bourlon C, Gabutti A, Gallegos C, Bourlon MT.
    Oncology (Williston Park); 2019 Jul 16; 33(7):. PubMed ID: 31365754
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acute localised exanthematous pustulosis secondary to pembrolizumab.
    Wang CY, Khoo C, McCormack CJ, Xu W, Pan Y.
    Australas J Dermatol; 2017 Nov 16; 58(4):322-323. PubMed ID: 28691194
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab in the treatment of pembrolizumab-induced myasthenia gravis.
    Crusz SM, Radunovic A, Shepherd S, Shah S, Newey V, Phillips M, Lim L, Powles T, Szlosarek PW, Shamash J, Rashid S.
    Eur J Cancer; 2018 Oct 16; 102():49-51. PubMed ID: 30138772
    [No Abstract] [Full Text] [Related]

  • 10. Vitiligo-like lesions located over In-transit metastases of malignant melanoma as a clinical marker of complete response to pembrolizumab.
    Gracia-Cazaña T, Padgett E, Hernández-García A, Sánchez-Salas MP.
    Dermatol Online J; 2019 Dec 15; 25(12):. PubMed ID: 32045170
    [Abstract] [Full Text] [Related]

  • 11. [Treating metastatic melanoma: Risk management].
    Lebbe C, Robert C.
    Ann Dermatol Venereol; 2017 Jan 15; 144(1):3-5. PubMed ID: 28063593
    [No Abstract] [Full Text] [Related]

  • 12. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
    Wada N, Uchi H, Furue M.
    J Dermatol; 2017 Oct 15; 44(10):e240-e241. PubMed ID: 28677843
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Birdshot-like Chorioretinopathy Associated With Pembrolizumab Treatment.
    Acaba-Berrocal LA, Lucio-Alvarez JA, Mashayekhi A, Ho AC, Dunn JP, Shields CL.
    JAMA Ophthalmol; 2018 Oct 01; 136(10):1205-1207. PubMed ID: 30054605
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.
    Russo I, Filoni A, Alaibac M.
    Eur J Dermatol; 2021 Feb 01; 31(1):99-100. PubMed ID: 33586650
    [No Abstract] [Full Text] [Related]

  • 17. Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma.
    Sanchez A, Montaudie H, Bory P, Belgodere X, Passeron T, Lacour JP, Picard A.
    JAMA Dermatol; 2018 Nov 01; 154(11):1354-1356. PubMed ID: 30326507
    [No Abstract] [Full Text] [Related]

  • 18. Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
    Gulati N, Carvajal RD, Postow MA, Wolchok JD, Krueger JG.
    Exp Dermatol; 2016 Jul 01; 25(7):553-4. PubMed ID: 27061281
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases.
    Blakeway EA, Elshimy N, Muinonen-Martin A, Marples M, Mathew B, Mitra A.
    Melanoma Res; 2019 Jun 01; 29(3):338-341. PubMed ID: 30762712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.